Assessing Biomarker Validity for Neuropathic Pain
A challenge facing clinicians regarding the diagnosis of small fiber neuropathies lies in the scarcity of objective biomarkers.
A challenge facing clinicians regarding the diagnosis of small fiber neuropathies lies in the scarcity of objective biomarkers.
Participants in the LCIG group demonstrated improved PD symptoms and quality of life compared to the other groups, but several cases of denervation and increased thermal thresholds were observed in patients treated with LCIG.